Comparison of the effects of pemafibrate and omega-3 fatty acid ethyl on fatty liver index in patients with dyslipidemia treated with statin: a sub-analysis from the PROUD48 study

BackgroundFatty liver index (FLI) calculated by using body mass index, waist circumference and levels of triglycerides and γ-glutamyl transpeptidase is a noninvasive biomarker for diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD), which is one of the high-risk conditions...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Yasutaka Takeda, Masato Furuhashi, Ichiro Sakuma, Shinya Hiramitsu, Mizuho Okada, Shinichiro Ueda, Naoki Kumashiro, Masaru Sakurai
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2025-05-01
Serier:	Frontiers in Endocrinology
Fag:	fatty liver index atherosclerotic cardiovascular disease residual risk hypertriglyceridemia nonalcoholic fatty liver disease metabolic dysfunction-associated fatty liver disease
Online adgang:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1549687/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!